Informa Markets

Article

The Japanese Pharma Market
27.07.2022 • TopicsStrategy

The Japanese Pharma Market

Japan continues to be one of the largest pharmaceutical markets in the world, making up approximately 7% of the global share. Historically, Japan has been viewed as insular compared to other developed markets such as Europe or the US, with foreign companies reporting high barriers to entry.

Short-Term Reshoring
29.10.2021 • NewsStrategy

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Covid-19 Driving Manufacturing, CDMOs Driving Growth
26.04.2021 • NewsStrategy

Covid-19 Driving Manufacturing, CDMOs Driving Growth

The CPhI executive post-pandemic pharma survey, produced by Informa Markets as part of the CPhI Pharma 2021 Report, predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next 5 years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.